Could a pill replace IV arsenic for leukemia patients?
Disease control
Not yet recruiting
This study tests if an oral (pill) form of arsenic trioxide works as well as the standard IV version for people with a low-risk type of acute promyelocytic leukemia (APL). About 120 adults and teens who have finished their first round of treatment will be randomly assigned to rec…
Phase: PHASE3 • Sponsor: SDK Therapeutics, Inc. • Aim: Disease control
Last updated May 11, 2026 20:40 UTC